# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001062822-24-000015
Filing Date
2024-03-26
Accepted
2024-03-26 07:06:29
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | a2024proxynotice03-26x2024.htm | DEFA14A | 20068
2 |  | image.jpg | GRAPHIC | 369176
3 |  | image1.jpg | GRAPHIC | 148863
4 |  | image2.jpg | GRAPHIC | 270652
5 |  | image3.jpg | GRAPHIC | 136411
| Complete submission text file | 0001062822-24-000015.txt |  | 1296175

Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30111 | Film No.: 24780880
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)